Communication is Key - The Gut, its Microbiome, Immune cells and the Brain
More and more studies show that a disbalance in the gut-microbiome can negatively impact patients suffering from various…
Biotechnology projects shaping our future - three life science start-ups convinced the jury at the 11th BioRiver Boost!
The winners of the 11th BioRiver Boost! 2024 have been announced. First place went to Munich-based ingineeon – advanced…
ImmunOs Therapeutics Announces Appointment of Joseph Leveque, MD, to its Board of Directors
ImmunOs Therapeutics AG, a biopharmaceutical company leveraging its HLA-based technology platform to develop first-in-cl…
Globaler Gmp-Zytokine Markt | Umsatz Ab Werk Preis Umsatz Bruttomarge Analyse 2022
In den letzten Jahren wurde ein immenses Wirtschaftswachstum auf dem globalen Gmp-Zytokine-Markt mit einer umfassenden S…
Immunic, Inc. Reports Second Quarter 2021 Financial Results and Highlights Recent Activity
– Received FDA Clearance to Initiate Twin IMU-838 Phase 3 ENSURE Trials in Relapsing-Remitting Multiple Sclerosis and Su…
Immunic, Inc. to Host Virtual R&D Day Today to Provide an Update on the Preclinical and Clinical Development of IMU-935, a Potentially Best-in-Class RORγt Inverse Agonist
. – IMU- 935 Has Been Observed In Vitro to Inhibit the Generation of Th17 Cells and Production of IL-17 Cytokines Withou…
Allero Therapeutics and Abbreos join forces to clinically develop COVID-19 program
Allero Therapeutics BV, a Belgian-Dutch oromucosal immunotherapy company, and Abbreos Inc., a US- based IND-stage compan…
Immunic, Inc. to Host Virtual R&D Day Today, May 19, 2020
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral thera…
Gustave Roussy et Biognosys annoncent leur partenariat
La pneumonie sévère chez les patients atteints du syndrome respiratoire aigu sévère du corovinarus-2 (SARS-Cov-2) requie…
Gustave Roussy and Biognosys Announce Partnership
The severe pneumonitis in patients infected by the severe acute respiratory syndrome coronavirus-2 (SARS-Cov-2) requires…